As in patients with both MG and thymoma [10,11], we detected antibodies against the more distantly related type I IFN, IFN-β (30% homology with IFN-α), much less frequently than against either IFN-α or IFN-ω, and at much lower titres (Tables 1 and 2; Figure 1A); we found them mostly in patients with especially high titres against IFN-α2 and IFN-ω (n = 15), and usually from the first sample onwards. This evidence concerns the gene IFNA2 and myasthenia gravis.